Literature DB >> 21934595

Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection.

Andrea L Mora1, Miguel Salazar, Juan Pablo-Caeiro, Craig P Frost, Yashoo Yadav, Herbert L DuPont, Kevin W Garey.   

Abstract

INTRODUCTION: Risk factors for Clostridium difficile infection (CDI) include use of broad-spectrum antibiotics, advanced age and lack of an appropriate immune response. Whether antiperistaltics such as opioid analgesics also increase the risk of CDI is uncertain. The purpose of this preliminary study was to determine whether opioid analgesics increase the risk of developing CDI in hospitalized patients receiving broad-spectrum antibiotics.
METHODS: Hospitalized patients were assessed for incidence of CDI in relation to usage of opioid analgesics controlling for other known risk factors for CDI.
RESULTS: During the study period, a total of 32,775 patients were identified of whom 192 had CDI. In univariate analysis, incidence of CDI increased significantly with moderate or high usage of opioids (P < 0.0001). One hundred of 21,396 (0.47%) patients who did not receive opioids developed CDI. Twenty-two of 6955 patients (0.32%) with mild usage of opioids developed CDI [odds ratio (OR): 0.68; 95% confidence interval (CI): 0.43-1.1; P = 0.10]. Thirty of 33,203 (0.93%) with moderate usage developed CDI (OR: 2.0; 95% CI: 1.3-3.0; P = 0.0009). Forty of 1029 (3.7%) patients with high usage of opioids developed CDI (OR: 8.3; 95% CI: 5.7-12.1; P < 0.0001). Similar results were observed using a multivariate Cox proportional hazard model.
CONCLUSIONS: Moderate to high use of opioid analgesics were associated with an increased risk of CDI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21934595     DOI: 10.1097/MAJ.0b013e31822f42eb

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  16 in total

1.  Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

Authors:  Nadiya Hussain; Muntaha Naeem; David J Pinato
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

2.  Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV.

Authors:  E Jennifer Edelman; Kirsha S Gordon; Kristina Crothers; Kathleen Akgün; Kendall J Bryant; William C Becker; Julie R Gaither; Cynthia L Gibert; Adam J Gordon; Brandon D L Marshall; Maria C Rodriguez-Barradas; Jeffrey H Samet; Amy C Justice; Janet P Tate; David A Fiellin
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

3.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

4.  Usual opioid dosing does not adversely affect the course of healthcare-associated Clostridioides difficile infection.

Authors:  Monica Chowdhry; Douglas Haden; Suzanne Kemper; Kristen Helmick; Muhammad Kawsara; Ashley Huggett; Andrea Stark; Ahmad Khan; Muhammad Shah; Mustafa Bhaty; Junaid Farooq; Shailendra Singh; Brittain McJunkin
Journal:  Pain Manag       Date:  2020-12-22

5.  Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.

Authors:  Rodrigo Duarte-Chavez; Thomas R Wojda; Thomas B Zanders; Berhanu Geme; Gloria Fioravanti; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun

6.  Nonsteroidal Anti-Inflammatory Drugs Impact on the Outcomes of Hospitalized Patients with Clostridium difficile Infection.

Authors:  Harish Patel; Jasbir Makker; Trupti Vakde; Danial Shaikh; Kanthi Badipatla; James Dunne; Nikhitha Mantri; Suresh Kumar Nayudu; Mariela Glandt; Bhavna Balar; Sridhar Chilimuri
Journal:  Clin Exp Gastroenterol       Date:  2019-12-10

7.  Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection.

Authors:  Elida Voth; Dipesh Solanky; Edward V Loftus; Darrell S Pardi; Sahil Khanna
Journal:  Therap Adv Gastroenterol       Date:  2021-03-12       Impact factor: 4.409

8.  Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.

Authors:  Ana C Thomaz; Vishakh Iyer; Taylor J Woodward; Andrea G Hohmann
Journal:  Exp Neurol       Date:  2021-06-18       Impact factor: 5.620

9.  Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).

Authors:  Andrea Ticinesi; Antonio Nouvenne; Giuseppina Folesani; Beatrice Prati; Ilaria Morelli; Loredana Guida; Francesca Turroni; Marco Ventura; Fulvio Lauretani; Marcello Maggio; Tiziana Meschi
Journal:  BMJ Open       Date:  2015-10-26       Impact factor: 2.692

10.  Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Timothy Johnson; Chi Chen; Sabita Roy
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.